Expression levels in different conditions, possible mechanisms of action and the effect of prognosis of ZG16B in breast cancer were presented, demonstrating its potential value to be a biomarker for breast cancer in clinical practice. The gene discussed is ZG16B; the disease is breast carcinoma.